The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.  Otiashvili D, Mgebrishvili T, B…

Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.  Bandara S, Maniates H, Hulsey E, Smith JS, DiDomenico E, Stuart EA, Saloner B, Krawczyk N.  BMC Health Serv Res. 2022 Mar 30;22(1):418. doi: 10.1…

Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19.  Suen LW, Coe WH, Wyatt JP, Adams ZM, Gandhi M, Batchelor HM, Castellanos S, Joshi N, Satterwhite S, Pérez-Rodríguez…

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.  Mattocks KM, Moore DT, Wischik DL, Lazar CM, Rosen MI.  J Subst Abuse Treat. 2022 Mar 25:108777. doi: 10.1016/j.jsat.2022…

Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic.  Dowd WN, Mark TL.  JAMA Netw Open. 2022 Mar 1;5(3):e224058. doi: 10.1001/jamanetworkopen.2022.4058. PMID: 35323952. https://…

Exploring the impact of COVID-19 on substance use patterns and service access of street involved individuals in Kingston, Ontario: a qualitative study.  McCann V, Allen R, Purkey E.  BMC Public Health. 2022 Mar 23;22(1):571. doi: 10.1186…